STOCK TITAN

[Form 4] Qualys, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Qualys, Inc. (QLYS) director Thomas Berquist reported sales of company common stock on 09/02/2025 executed under a Rule 10b5-1 trading plan adopted February 19, 2025. The Form 4 discloses three sale transactions: 150 shares at a weighted average price of $132.1767, 325 shares at $133.4115, and 37 shares at $133.93. Following these dispositions, the reported beneficial ownership totals shown on the form decreased from prior levels to 5,454; then 5,129; then 5,092 shares as reflected on each reported line.

The filing was signed on behalf of Mr. Berquist by power of attorney on 09/03/2025. The Form 4 notes that the seller will provide detailed per-price share counts to the Commission upon request. No derivative transactions, grants, or acquisitions are reported in this filing.

Thomas Berquist, amministratore di Qualys, Inc. (QLYS) ha segnalato la vendita di azioni ordinarie della società il 02/09/2025 eseguita nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 19 febbraio 2025. Il Modulo 4 indica tre operazioni di vendita: 150 azioni a un prezzo medio ponderato di $132,1767, 325 azioni a $133,4115 e 37 azioni a $133,93. Dopo queste cessioni, la detenzione beneficiaria riportata nel modulo è diminuita rispetto ai livelli precedenti a 5.454; poi a 5.129; poi a 5.092 azioni, come indicato in ciascuna riga del rapporto.

Il deposito è stato firmato per conto del Sig. Berquist tramite procura il 03/09/2025. Il Modulo 4 precisa che il venditore fornirà, su richiesta della Commissione, il dettaglio delle quantità per ciascun prezzo. In questo deposito non sono riportate transazioni su strumenti derivati, assegnazioni o acquisizioni.

Thomas Berquist, director de Qualys, Inc. (QLYS), informó ventas de acciones ordinarias de la compañía el 02/09/2025 ejecutadas bajo un plan de negociación conforme a la Regla 10b5-1 adoptado el 19 de febrero de 2025. El Formulario 4 divulga tres operaciones de venta: 150 acciones a un precio medio ponderado de $132.1767, 325 acciones a $133.4115 y 37 acciones a $133.93. Tras estas disposiciones, la propiedad beneficiaria informada en el formulario disminuyó respecto a los niveles previos a 5.454; luego 5.129; luego 5.092 acciones, según figura en cada línea reportada.

La presentación fue firmada en nombre del Sr. Berquist mediante poder el 03/09/2025. El Formulario 4 indica que el vendedor proporcionará a la Comisión, a solicitud, el desglose de acciones por precio. En este envío no se informan transacciones con derivados, concesiones ni adquisiciones.

Qualys, Inc.(QLYS) 이사 토마스 버퀴스트(Thomas Berquist)는 2025년 9월 2일 회사 보통주 매도를 보고했으며, 해당 매도는 2025년 2월 19일 채택된 Rule 10b5-1 거래 계획에 따라 실행되었습니다. Form 4는 세 건의 매도 거래를 공시하고 있습니다: 가중평균가 $132.1767에 150주, $133.4115에 325주, $133.93에 37주. 이 처분들로 인해 양식에 보고된 실소유 지분은 이전 수준에서 각 보고 줄에 반영된 바와 같이 5,454주 → 5,129주 → 5,092주로 감소했습니다.

해당 제출서는 2025년 9월 3일 위임장을 통해 버퀴스트 씨를 대신하여 서명되었습니다. Form 4는 판매자가 요청 시 가격별 주식 수량을 위원회에 제공할 것임을 명시하고 있습니다. 이 제출서에는 파생상품 거래, 부여 또는 취득은 보고되어 있지 않습니다.

Thomas Berquist, administrateur de Qualys, Inc. (QLYS), a déclaré la vente d'actions ordinaires de la société le 02/09/2025, exécutée dans le cadre d'un plan de négociation conforme à la Rule 10b5-1 adopté le 19 février 2025. Le Formulaire 4 divulgue trois opérations de vente : 150 actions au prix moyen pondéré de 132,1767 $, 325 actions à 133,4115 $ et 37 actions à 133,93 $. À la suite de ces cessions, la propriété bénéficiaire déclarée sur le formulaire a diminué par rapport aux niveaux antérieurs à 5 454 ; puis 5 129 ; puis 5 092 actions, comme indiqué sur chaque ligne rapportée.

Le dépôt a été signé au nom de M. Berquist par procuration le 03/09/2025. Le Formulaire 4 précise que le vendeur fournira, sur demande de la Commission, le détail des nombres d'actions par prix. Aucune transaction sur dérivés, attribution ou acquisition n'est signalée dans ce dépôt.

Thomas Berquist, Direktor von Qualys, Inc. (QLYS), meldete den Verkauf von Stammaktien des Unternehmens am 02.09.2025, ausgeführt im Rahmen eines nach Rule 10b5-1 eingerichteten Handelsplans, der am 19. Februar 2025 angenommen wurde. Das Formular 4 gibt drei Verkaufs-transaktionen an: 150 Aktien zu einem gewichteten Durchschnittspreis von $132,1767, 325 Aktien zu $133,4115 und 37 Aktien zu $133,93. Nach diesen Veräußerungen verringerten sich die im Formular angegebenen wirtschaftlichen Beteiligungen gegenüber dem vorherigen Stand auf 5.454; dann 5.129; dann 5.092 Aktien, wie in den einzelnen gemeldeten Zeilen dargestellt.

Die Einreichung wurde am 03.09.2025 im Namen von Herrn Berquist per Vollmacht unterschrieben. Das Formular 4 weist darauf hin, dass der Verkäufer auf Anfrage der Kommission detaillierte Stückzahlen pro Preis vorlegen wird. In dieser Einreichung werden keine Derivatgeschäfte, Zuwendungen oder Erwerbe gemeldet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine insider sales under a pre-established 10b5-1 plan; reduces holdings but appears procedural, not event-driven.

The reported transactions are disclosed as sales executed pursuant to a Rule 10b5-1 trading plan adopted on February 19, 2025, which typically provides an affirmative defense to insider trading claims by scheduling trades in advance. The sizes of the trades (totaling 512 shares) are modest relative to typical institutional holdings and no options or derivative activity are shown. The filing documents declining beneficial ownership across the reported lines and a POA signature, indicating administrative handling of the Form 4.

TL;DR: Compliance-focused disclosure; 10b5-1 plan use and POA signature reflect governance controls.

The Form 4 provides clear disclosure that sales were executed under a pre-approved 10b5-1 trading plan, which aligns with good governance practices for insiders disposing of shares. The inclusion of weighted-average sale prices and an explicit offer to provide per-price share counts upon request demonstrates transparency. The filing does not indicate any acceleration, exemptions, or related-party transactions.

Thomas Berquist, amministratore di Qualys, Inc. (QLYS) ha segnalato la vendita di azioni ordinarie della società il 02/09/2025 eseguita nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 19 febbraio 2025. Il Modulo 4 indica tre operazioni di vendita: 150 azioni a un prezzo medio ponderato di $132,1767, 325 azioni a $133,4115 e 37 azioni a $133,93. Dopo queste cessioni, la detenzione beneficiaria riportata nel modulo è diminuita rispetto ai livelli precedenti a 5.454; poi a 5.129; poi a 5.092 azioni, come indicato in ciascuna riga del rapporto.

Il deposito è stato firmato per conto del Sig. Berquist tramite procura il 03/09/2025. Il Modulo 4 precisa che il venditore fornirà, su richiesta della Commissione, il dettaglio delle quantità per ciascun prezzo. In questo deposito non sono riportate transazioni su strumenti derivati, assegnazioni o acquisizioni.

Thomas Berquist, director de Qualys, Inc. (QLYS), informó ventas de acciones ordinarias de la compañía el 02/09/2025 ejecutadas bajo un plan de negociación conforme a la Regla 10b5-1 adoptado el 19 de febrero de 2025. El Formulario 4 divulga tres operaciones de venta: 150 acciones a un precio medio ponderado de $132.1767, 325 acciones a $133.4115 y 37 acciones a $133.93. Tras estas disposiciones, la propiedad beneficiaria informada en el formulario disminuyó respecto a los niveles previos a 5.454; luego 5.129; luego 5.092 acciones, según figura en cada línea reportada.

La presentación fue firmada en nombre del Sr. Berquist mediante poder el 03/09/2025. El Formulario 4 indica que el vendedor proporcionará a la Comisión, a solicitud, el desglose de acciones por precio. En este envío no se informan transacciones con derivados, concesiones ni adquisiciones.

Qualys, Inc.(QLYS) 이사 토마스 버퀴스트(Thomas Berquist)는 2025년 9월 2일 회사 보통주 매도를 보고했으며, 해당 매도는 2025년 2월 19일 채택된 Rule 10b5-1 거래 계획에 따라 실행되었습니다. Form 4는 세 건의 매도 거래를 공시하고 있습니다: 가중평균가 $132.1767에 150주, $133.4115에 325주, $133.93에 37주. 이 처분들로 인해 양식에 보고된 실소유 지분은 이전 수준에서 각 보고 줄에 반영된 바와 같이 5,454주 → 5,129주 → 5,092주로 감소했습니다.

해당 제출서는 2025년 9월 3일 위임장을 통해 버퀴스트 씨를 대신하여 서명되었습니다. Form 4는 판매자가 요청 시 가격별 주식 수량을 위원회에 제공할 것임을 명시하고 있습니다. 이 제출서에는 파생상품 거래, 부여 또는 취득은 보고되어 있지 않습니다.

Thomas Berquist, administrateur de Qualys, Inc. (QLYS), a déclaré la vente d'actions ordinaires de la société le 02/09/2025, exécutée dans le cadre d'un plan de négociation conforme à la Rule 10b5-1 adopté le 19 février 2025. Le Formulaire 4 divulgue trois opérations de vente : 150 actions au prix moyen pondéré de 132,1767 $, 325 actions à 133,4115 $ et 37 actions à 133,93 $. À la suite de ces cessions, la propriété bénéficiaire déclarée sur le formulaire a diminué par rapport aux niveaux antérieurs à 5 454 ; puis 5 129 ; puis 5 092 actions, comme indiqué sur chaque ligne rapportée.

Le dépôt a été signé au nom de M. Berquist par procuration le 03/09/2025. Le Formulaire 4 précise que le vendeur fournira, sur demande de la Commission, le détail des nombres d'actions par prix. Aucune transaction sur dérivés, attribution ou acquisition n'est signalée dans ce dépôt.

Thomas Berquist, Direktor von Qualys, Inc. (QLYS), meldete den Verkauf von Stammaktien des Unternehmens am 02.09.2025, ausgeführt im Rahmen eines nach Rule 10b5-1 eingerichteten Handelsplans, der am 19. Februar 2025 angenommen wurde. Das Formular 4 gibt drei Verkaufs-transaktionen an: 150 Aktien zu einem gewichteten Durchschnittspreis von $132,1767, 325 Aktien zu $133,4115 und 37 Aktien zu $133,93. Nach diesen Veräußerungen verringerten sich die im Formular angegebenen wirtschaftlichen Beteiligungen gegenüber dem vorherigen Stand auf 5.454; dann 5.129; dann 5.092 Aktien, wie in den einzelnen gemeldeten Zeilen dargestellt.

Die Einreichung wurde am 03.09.2025 im Namen von Herrn Berquist per Vollmacht unterschrieben. Das Formular 4 weist darauf hin, dass der Verkäufer auf Anfrage der Kommission detaillierte Stückzahlen pro Preis vorlegen wird. In dieser Einreichung werden keine Derivatgeschäfte, Zuwendungen oder Erwerbe gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Berquist Thomas

(Last) (First) (Middle)
C/O QUALYS, INC.
919 E. HILLSDALE BLVD.

(Street)
FOSTER CITY CA 94404

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
QUALYS, INC. [ QLYS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 S(1) 150 D $132.1767(2) 5,454 D
Common Stock 09/02/2025 S(1) 325 D $133.4115(3) 5,129 D
Common Stock 09/02/2025 S(1) 37 D $133.93 5,092 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2025.
2. The sale price represents the weighted average price of the shares sold ranging from $131.55 to $132.50 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
3. The sale price represents the weighted average price of the shares sold ranging from $132.93 to $133.78 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
/s/ Bruce Posey, by power of attorney 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Qualys Inc

NASDAQ:QLYS

QLYS Rankings

QLYS Latest News

QLYS Latest SEC Filings

QLYS Stock Data

4.85B
35.89M
0.59%
99.52%
8.4%
Software - Infrastructure
Services-prepackaged Software
Link
United States
FOSTER CITY